Evaluation of Abbreviated Versus Conventional Course of Dabigatran Etexilate Before Electric Cardioversion in Patients With Atrial Fibrillation (RE-SOUND Study)

PHASE4UnknownINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

December 28, 2017

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions

Atrial Fibrillation

Interventions

DRUG

dabigatran etexilate

150 mg twice daily (BID)

Trial Locations (1)

RECRUITING

"Limited Liability Company Medical Association Novaya Bolnitsa", Yekaterinburg